Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12565004 | 0.79 | TERT (0.50) | GABRA1GABRB2DAOTERTMEN1 | |
| SCHEMBL15119498 | 0.76 | MEN1 (0.53) | GABRA1GABRB2DAOKDM4ETERT | |
| SCHEMBL25519641 | 0.72 | GABRA1 (0.44) | GABRA1GABRB2KDM4E | |
| SCHEMBL10496032 | 0.71 | KMT2A (0.44) | GABRA1GABRB2DAOKDM4ETERT | |
| SCHEMBL7566755 | 0.70 | TERT (0.46) | GABRA1GABRB2TERTPARP1KAT6A | |
| SCHEMBL27416308 | 0.69 | PARP1 (0.61) | KDM4ETERTPARP1 | |
| SCHEMBL23753971 | 0.68 | TERT (0.38) | GABRA1GABRB2DAOTERTMEN1 | |
| SCHEMBL14047371 | 0.68 | DRD4 (0.43) | KDM4EMEN1KMT2APARP1ATM | |
| SCHEMBL28827733 | 0.68 | KMT2A (0.53) | GABRA1GABRB2DAOTERTMEN1 | |
| SCHEMBL3988403 | 0.67 | GABRA1 (0.70) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023086428-A2 | NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF | ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-05-19 | — | — | WO | disclosed |